A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Annika Smith
Westmead Hospital
Principal Investigator - Deirdre Murrell
Premier Specialist
Principal Investigator - Ira Thorla
Louisiana Dermatology Associates
Principal Investigator - Ivette Espinosa-Fernandez
Revival Research Institute
Principal Investigator - James Krell
Total Skin and Beauty Dermatology Center
Principal Investigator - Jennifer Soung
Southern California Dermatology, Inc
Principal Investigator - Jose Cardona
Indago Research and Health Center
Principal Investigator - Lynda Spelman
Veracity Clinical Trials Ltd
Principal Investigator - Paul Yamauchi
Clinical Science Institute
Principal Investigator - Samantha Eisman
Sinclair Dermatology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Premier Specialist
Kogarah, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Veracity Clinical Trials Ltd
Woolloongabba, Queensland, Australia
- Sinclair Dermatology
East Melbourne, Victoria, Australia
- Total Skin and Beauty Dermatology Center
Birmingham, Alabama, United States
- Southern California Dermatology, Inc
Santa Ana, California, United States
- Clinical Science Institute
Santa Monica, California, United States
- Revival Research Institute
Doral, Florida, United States
- Indago Research and Health Center
Hialeah, Florida, United States
- Louisiana Dermatology Associates - Dermatology
Baton Rouge, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Nov 2021
- Primary completion
- 8 Nov 2023
- Completion
- 7 Oct 2024
- Last update posted
- 7 Jan 2025
- Registered enrollment
- 80
- Registry id
- NCT04911751
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.